Publications by authors named "Alexandra Kourouklidou"
Article Synopsis
- Pain from hidradenitis suppurativa (HS) drastically affects patients' quality of life, and finding effective management strategies remains a challenge.
- Adalimumab, a TNF-a antagonist, has shown promising results in reducing pain associated with HS, as evidenced by a significant mean pain score reduction in a meta-analysis of multiple studies.
- The findings support the broader prescription of adalimumab for patients with HS who experience significant pain, indicating its potential as an effective treatment option.
Molecular targeting therapies represent a new exciting era in dermatology. A promising novel drug class, subject of intense research, is Janus kinase (JAK) inhibitors. Multiple cytokine receptors signal through the Janus kinase and signal transducer and activator of transcription (STAT) pathway.
View Article and Find Full Text PDF